Journal of Clinical Endocrinology & Metabolism, Vol 80, 1566-1570, Copyright © 1995 by Endocrine Society

ARTICLES

Multihormonal regulation of progesterone synthesis in cultured human midluteal cells

L Devoto, P Kohen, O Castro, M Vega, JL Troncoso and E Charreau
University of Chile School of Medicine, Santiago.

The objectives of this investigation were to examine in vivo insulin like-growth factor-I (IGF-I) secretion by the human midcorpora lutea (mid-CL) and the effects of IGF-I, hCG, FSH, and human GH on progesterone (P) production by CL cells obtained from patients at laparotomy. We first examined whether the CL produces IGF-I by measuring IGF-I levels in the ovarian vein from the ovary bearing the CL. The IGF-I concentration in the ovarian vein bearing the CL (206 +/- 31 ng/mL) was significantly increased compared to the concentration in the contralateral ovarian vein (179.2 +/- 32 ng/mL; P < 0.05). Luteal cells isolated from mid-CL were cultured in serum-free medium 199 in the presence and absence of hCG, FSH, GH, and graded concentrations of IGF-I. At the end of the incubation period (24 h), P levels in the medium were measured by RIA. The treatment with IGF-I (0.1-10 ng/mL) showed a dose-dependent stimulatory action of IGF-I on P synthesis in the luteal cell system, being maximal between 5-10 ng/mL. The treatment with hCG (10 IU/mL), IGF-I (5 ng/mL), and GH (1000 ng/mL) increased basal P synthesis by 300%, 80%, and 30%, respectively (P < 0.001 and P < 0.05). FSH (100 ng/mL), either alone or in combination with IGF-I, failed to stimulate P synthesis. Treatment with IGF-I monoclonal antibody (1:5000) completely reduced P synthesis induced by 5 ng/mL IGF- I and slightly reduced basal P synthesis as well as GH-stimulated P synthesis by human midluteal cells. To further evaluate the specific role of IGF-I on luteal steroidogenesis, IGF-I receptor was identified by chemical cross-linking of [125I]IGF-I to mid-CL membranes. Experiments conducted in the absence and presence of unlabeled IGF-I (500 ng) revealed proteins with characteristics of the type I IGF receptor. These results are consistent with multihormonal regulation of P synthesis by the human mid-CL. hCG and IGF-I play a major role in the stimulation of P synthesis and, to a lesser extent, human GH. These in vivo and in vitro data suggest that the CL is a site of secretion, action, and reception of IGF-I during the midluteal phase.

This article has been cited by other articles:

				F. Del Canto, W. Sierralta, P. Kohen, A. Munoz, J. F. Strauss III, and L. Devoto Features of Natural and Gonadotropin-Releasing Hormone Antagonist-Induced Corpus Luteum Regression and Effects of in Vivo Human Chorionic Gonadotropin J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4436 - 4443. [Abstract] [Full Text] [PDF]

				P. Kohen, O. Castro, A. Palomino, A. Munoz, L. K. Christenson, W. Sierralta, P. Carvallo, J. F. Strauss III, and L. Devoto The Steroidogenic Response and Corpus Luteum Expression of the Steroidogenic Acute Regulatory Protein after Human Chorionic Gonadotropin Administration at Different Times in the Human Luteal Phase J. Clin. Endocrinol. Metab., July 1, 2003; 88(7): 3421 - 3430. [Abstract] [Full Text] [PDF]

				L. Devoto, P. Kohen, R. R. Gonzalez, O. Castro, I. Retamales, M. Vega, P. Carvallo, L. K. Christenson, and J. F. Strauss III Expression of Steroidogenic Acute Regulatory Protein in the Human Corpus Luteum throughout the Luteal Phase J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5633 - 5639. [Abstract] [Full Text] [PDF]

				H. M. Fraser, S. F. Lunn, H. Kim, W. C. Duncan, F. E. Rodger, P. J. Illingworth, and G. F. Erickson Changes in Insulin-like Growth Factor-Binding Protein-3 Messenger Ribonucleic Acid in Endothelial Cells of the Human Corpus Luteum: A Possible Role in Luteal Development and Rescue J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1672 - 1677. [Abstract] [Full Text]

				U. Ottander, K. Hosokawa, K. Liu, A. Bergh, T. Ny, and J. I. Olofsson A Putative Stimulatory Role of Progesterone Acting via Progesterone Receptors in the Steroidogenic Cells of the Human Corpus Luteum Biol Reprod, March 1, 2000; 62(3): 655 - 663. [Abstract] [Full Text]

				G. D. Niswender, J. L. Juengel, P. J. Silva, M. K. Rollyson, and E. W. McIntush Mechanisms Controlling the Function and Life Span of the Corpus Luteum Physiol Rev, January 1, 2000; 80(1): 1 - 29. [Abstract] [Full Text] [PDF]

				P. Kohen, A. Castro, P. Caballero-Campo, O. Castro, M. Vega, A. Makrigiannakis, C. Simón, P. Carvallo, and L. Devoto Interleukin-1{beta} (IL-1{beta}) Is a Modulator of Human Luteal Cell Steroidogenesis: Localization of the IL Type I System in the Corpus Luteum J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 4239 - 4245. [Abstract] [Full Text]

				R. Apa, F. Miceli, E. Pierro, F. Minici, P. Navarra, A. Caruso, M. Napolitano, S. Mancuso, and A. Lanzone Paracrine Regulation of Insulin-Like Growth Factor I (IGF-I) and IGF-II on Prostaglandins F2{alpha} and E2 Synthesis by Human Corpus Luteum in Vitro: A Possible Balance of Luteotropic and Luteolytic Effects J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2507 - 2512. [Abstract] [Full Text]